These polymorphisms may also influence VDR expression levels in HNC tissues, potentially amplifying or dampening the anti-tumor effects of vitamin D supplementation, thus shaping individual responses to therapy and survival outcomes. The gene discussed is VDR; the disease is neoplasm.